Stockscreener 앱 받기
22.80
4.18%
-0.995
시간 외 거래:
22.84
0.035
+0.15%
전일 마감가:
$23.80
열려 있는:
$23.76
하루 거래량:
4.27M
Relative Volume:
0.80
시가총액:
$11.34B
수익:
$4.45B
순이익/손실:
$205.00M
주가수익비율:
57.01
EPS:
0.4
순현금흐름:
$372.00M
1주 성능:
+0.77%
1개월 성능:
+4.13%
6개월 성능:
+57.60%
1년 성능:
+93.26%
1일 변동 폭
$22.79
$23.81
1주일 범위
$22.00
$23.89
52주 변동 폭
$8.02
$23.89
엘란코 Stock (ELAN) Company Profile
명칭
Elanco Animal Health Inc
전화
877-352-6261
주소
450 ELANCO CIRCLE, INDIANAPOLIS
ELAN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ELAN
Elanco Animal Health Inc
|
22.82 | 11.83B | 4.45B | 205.00M | 372.00M | 0.40 |
|
ZTS
Zoetis Inc
|
125.66 | 57.00B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.90 | 49.88B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
10.05 | 45.73B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
32.39 | 36.84B | 16.88B | 666.71M | 251.19M | 0.6132 |
|
RGC
Regencell Bioscience Holdings Ltd
|
52.72 | 16.33B | 0 | -5.87M | -767.30K | -0.45 |
엘란코 Stock (ELAN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-09 | 개시 | Barclays | Overweight |
| 2025-11-21 | 개시 | KeyBanc Capital Markets | Overweight |
| 2025-11-19 | 업그레이드 | Argus | Hold → Buy |
| 2025-10-07 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2025-07-17 | 업그레이드 | Leerink Partners | Market Perform → Outperform |
| 2025-06-26 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-12-09 | 개시 | UBS | Buy |
| 2024-12-02 | 개시 | Leerink Partners | Market Perform |
| 2024-09-19 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2024-01-05 | 업그레이드 | Stifel | Hold → Buy |
| 2023-12-19 | 개시 | Jefferies | Buy |
| 2023-12-15 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2023-12-07 | 개시 | Exane BNP Paribas | Outperform |
| 2023-04-20 | 업그레이드 | Barclays | Equal Weight → Overweight |
| 2022-08-18 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-16 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-07-21 | 다운그레이드 | Goldman | Buy → Sell |
| 2022-07-12 | 개시 | Piper Sandler | Neutral |
| 2021-11-18 | 개시 | Morgan Stanley | Overweight |
| 2021-10-28 | 다운그레이드 | Stifel | Buy → Hold |
| 2021-08-05 | 재개 | Credit Suisse | Outperform |
| 2021-06-15 | 업그레이드 | Cleveland Research | Underperform → Neutral |
| 2021-05-11 | 업그레이드 | Barclays | Underweight → Equal Weight |
| 2021-05-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2021-04-15 | 개시 | Stifel | Buy |
| 2021-03-22 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2021-02-26 | 업그레이드 | Credit Suisse | Neutral → Outperform |
| 2020-12-09 | 다운그레이드 | Argus | Buy → Hold |
| 2020-11-09 | 다운그레이드 | Barclays | Overweight → Underweight |
| 2020-08-20 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2020-08-13 | 재개 | Credit Suisse | Neutral |
| 2020-08-04 | 재개 | Goldman | Buy |
| 2020-07-27 | 다운그레이드 | Cleveland Research | Neutral → Underperform |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-10 | 개시 | Raymond James | Mkt Perform |
| 2019-12-19 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-11-07 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2019-09-23 | 개시 | Barclays | Overweight |
| 2019-08-26 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-08-15 | 업그레이드 | UBS | Sell → Neutral |
| 2019-05-23 | 개시 | Guggenheim | Neutral |
| 2019-03-18 | 업그레이드 | BofA/Merrill | Neutral → Buy |
| 2019-03-13 | 재개 | Morgan Stanley | Equal-Weight |
| 2019-02-12 | 개시 | William Blair | Mkt Perform |
| 2019-01-23 | 개시 | UBS | Sell |
| 2019-01-15 | 개시 | Argus | Buy |
| 2018-10-15 | 개시 | Morgan Stanley | Equal-Weight |
모두보기
엘란코 주식(ELAN)의 최신 뉴스
Assessing Elanco Animal Health (ELAN) Valuation After Befrena Approval And Turnaround Progress - Yahoo Finance
Veterinary Pain Management Drugs Market to hit US$ 3.00 Billion - openPR.com
Analysts Offer Insights on Healthcare Companies: Elanco Animal Health (ELAN), IQVIA Holdings (IQV) and Ascendis Pharma (ASND) - The Globe and Mail
Elanco Animal Health stock hits 52-week high at 23.71 USD - Investing.com Canada
Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference - Finviz
Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference – Company Announcement - Financial Times
3 Reasons to Avoid ELAN and 1 Stock to Buy Instead - Finviz
On-Farm Veterinary Diagnostic Solutions Market Booming with - openPR.com
Dogs Vaccines Market Strong Growth: New Report Highlights - openPR.com
Elanco Animal Health Inc (ELAT) Fundamental Analysis - Meyka
Breaking News - Today's Veterinary Business
ELAN SEC FilingsElanco Animal Health 10-K, 10-Q, 8-K Forms - Stock Titan
Elanco (ELAN) Gains USDA Approval for Befrena Injections - GuruFocus
Elanco (ELAN) Gains USDA Approval for New Canine Dermatology Tre - GuruFocus
Elanco gains approval of Befrena for canine dermatitis - Seeking Alpha
Elanco receives USDA approval for canine dermatitis treatment By Investing.com - Investing.com Canada
Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis - PR Newswire
Voya Investment Management LLC Sells 2,335,093 Shares of Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco (ELAN) CEO Jeffrey Simmons reports new deferred stock units - Stock Titan
Elanco (ELAN) EVP reports new deferred stock units award - Stock Titan
Targets Report: Will Elanco Animal Health Incorporated 5EA stock outperform value peers2025 EndofYear Setup & Free Low Drawdown Momentum Trade Ideas - moha.gov.vn
Yousif Capital Management LLC Boosts Stock Holdings in Elanco Animal Health Incorporated $ELAN - MarketBeat
EBITDA per share of Elanco Animal Health, Inc. – FWB:5EA - TradingView — Track All Markets
Elanco Animal Health Incorporated (NYSE:ELAN) Given Consensus Rating of "Moderate Buy" by Analysts - MarketBeat
Elanco Animal Health Incorporated (NYSE:ELAN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Elanco Animal Health Incorporated $ELAN Shares Sold by Harbor Capital Advisors Inc. - MarketBeat
Exchange Traded Concepts LLC Acquires Shares of 262,281 Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health Earnings Notes - Trefis
Elanco Animal Health Inc (ELAN) director gifts 60,000 shares - Stock Titan
Elanco Animal Health working to combat New World screwwrorm - norfolkneradio.com
Oasis of Zen - Exhibitor Online
Middle East And Africa Animal Healthcare Market Forecast - openPR.com
Jim Cramer on Elanco Animal Health: "They Are Doing Everything Right" - Finviz
How Conditional FDA Approval of Credelio Quattro-CA1 Could Impact Elanco Animal Health (ELAN) Investors - Yahoo Finance
Jim Cramer on Elanco Animal Health: “They Are Doing Everything Right” - Yahoo Finance
Douglas Lane & Associates LLC Cuts Stake in Elanco Animal Health Incorporated $ELAN - MarketBeat
Elanco Animal Health (FRA:5EA) EV-to-OCF : 22.34 (As of Dec. 21, 2025) - GuruFocus
Does Elanco’s 85% 2025 Rally Match Its Long Term Valuation Prospects? - Yahoo Finance
Veterinary Medicine Market Size to Hit USD 98.51 Billion by 2033, Growing at a CAGR of 8.11%SNS Insider - GlobeNewswire
Wall Street Zen Downgrades Elanco Animal Health (NYSE:ELAN) to Buy - MarketBeat
Is Elanco Animal Health Incorporated stock dividend yield sustainableJuly 2025 Levels & Risk Controlled Swing Alerts - ulpravda.ru
Is Elanco Animal Health Incorporated stock a contrarian opportunityTrade Ideas & Weekly High Potential Stock Alerts - Улправда
Stifel maintains Buy rating on Elanco Animal Health stock with $27 price target - Investing.com Canada
Will Elanco Animal Health Incorporated stock benefit from automationEarnings Summary Report & AI Enhanced Trading Signals - Bölüm Sonu Canavarı
Elanco CEO Bites Off More Shares of Fast-Rising Stock - Barron's
Is Elanco Animal Health Incorporated (5EA) stock positioned for digital growth eraTrade Risk Assessment & Target Return Focused Picks - DonanımHaber
Companion Animal Vaccine Market is Going to Boom: New Report - openPR.com
Hedge Fund and Insider Trading News: Bill Ackman, Warren Buffett, Steve Cohen, Citadel Investment Group, Elliott Management, Altai Capital, Elanco Animal Health Inc (ELAN), NVIDIA Corp (NVDA), and More - Insider Monkey
Elanco focused on production animals - norfolkneradio.com
Elanco Animal Health (NYSE:ELAN) Price Target Raised to $22.00 - MarketBeat
FDA conditionally approves Elanco’s treatment for screwworm in dogs By Investing.com - Investing.com Australia
엘란코 (ELAN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.39%
1.82%
자본화:
|
볼륨(24시간):